HomeCompareLFLS vs MRK

LFLS vs MRK: Dividend Comparison 2026

LFLS yields 4000.00% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LFLS wins by $7175340620755.81M in total portfolio value
10 years
LFLS
LFLS
● Live price
4000.00%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7175340620755.87M
Annual income
$6,839,006,593,197,835,000.00
Full LFLS calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — LFLS vs MRK

📍 LFLS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLFLSMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LFLS + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LFLS pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LFLS
Annual income on $10K today (after 15% tax)
$340,000.00/yr
After 10yr DRIP, annual income (after tax)
$5,813,155,604,218,160,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, LFLS beats the other by $5,813,155,604,218,152,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LFLS + MRK for your $10,000?

LFLS: 50%MRK: 50%
100% MRK50/50100% LFLS
Portfolio after 10yr
$3587670310377.96M
Annual income
$3,419,503,296,598,923,000.00/yr
Blended yield
95.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

LFLS
No analyst data
Altman Z
-15087.2
Piotroski
5/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LFLS buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLFLSMRK
Forward yield4000.00%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$7175340620755.87M$57.7K
Annual income after 10y$6,839,006,593,197,835,000.00$10,113.78
Total dividends collected$7152397773804.84M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LFLS vs MRK ($10,000, DRIP)

YearLFLS PortfolioLFLS Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$410,700$400,000.00$11,213$373.04+$399.5KLFLS
2$15,792,720$15,353,271.03$12,667$512.06+$15.78MLFLS
3$568,657,142$551,758,931.89$14,439$708.14+$568.64MLFLS
4$19,176,207,860$18,567,744,718.20$16,640$988.16+$19176.19MLFLS
5$605,696,028,890$585,177,486,479.73$19,432$1,394.07+$605696.01MLFLS
6$17,922,210,653,594$17,274,115,902,681.27$23,057$1,992.90+$17922210.63MLFLS
7$496,869,793,504,300$477,693,028,104,954.00$27,889$2,894.79+$496869793.48MLFLS
8$12,908,672,105,251,704$12,377,021,426,202,104.00$34,518$4,286.29+$12908672105.22MLFLS
9$314,330,866,876,668,540$300,518,587,724,049,200.00$43,912$6,494.35+$314330866876.62MLFLS
10$7,175,340,620,755,871,000$6,839,006,593,197,835,000.00$57,714$10,113.78+$7175340620755.81MLFLS

LFLS vs MRK: Complete Analysis 2026

LFLSStock

Loans4Less.Com, Inc. operates as an online mortgage brokerage firm primarily in the United States. The company intends to develop into a national advertising platform for standard 'A' paper conforming residential mortgage programs and other service providers. It also provides CA rates, terms and costs, daily rate updates, and other market information, as well as real estate brokerage services. The company distributes its products and services to the public via its Website Loans4Less.com. Loans4Less.Com, Inc. was founded in 1993 and is based in Redondo Beach, California.

Full LFLS Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this LFLS vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LFLS vs SCHDLFLS vs JEPILFLS vs OLFLS vs KOLFLS vs MAINLFLS vs JNJLFLS vs ABBVLFLS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.